| Term 
 | Definition 
 
        | 
 
certain aa's in the CNS bind post-synaptic receptors and act as inhibitory or excitatory neurotransmittersinhib/excitatory response is elicited by altering conductance of 1 or more ion-selective channels |  | 
        |  | 
        
        | Term 
 
        | γ-aminobutyric acid (GABA) |  | Definition 
 
        | 
 
major inhibitory amino acid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 
primary excitatory amino acid |  | 
        |  | 
        
        | Term 
 
        | GABAergic neurotransmission |  | Definition 
 
        | 
 
what most current drugs modulate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
widely distributed in CNSconsists of protein subunits with a central ion channelhave α,β, γ subunits familiesGABAA is targeted by largest # of drugs   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
5 subunits, surround central Cl- ion pore that opens in presence of GABADifferent receptor subtypes play distinct roles in specific neural circiuts   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
expressed at lower levels than GABAA mostly in spinal cordtargeted by only a few agents for spasticity   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | not yet used as a target of pharmacologic agents |  | 
        |  | 
        
        | Term 
 
        | drugs that modulate GABA receptors |  | Definition 
 
        |   
affect arousal and attention, memory formation, anxiety, sleep, and muscle toneimportant mech for treatment of focal or widespread neural hyperactivity in epilepsycan act at pre- or post-synaptically   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | occur when the ligand binds to a different site on the receptor to either inhibit or potentiate response   
i.e. benzodiazepines act as + allosteric modulators by binding noncompetitively to ion channels activated by GABA, enhancing the net effect of GABA on channel conductance   |  | 
        |  | 
        
        | Term 
 
        | Agents that activate GABAA receptors |  | Definition 
 
        |   
used for sedation, anxiolysis, hypnosis, neuro-protection following stroke or head trauma, control of epilepsyTiagabine (Gabitril), Benzodiazepines, Barbiturates, Baclofen (GABAB receptor agonist)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | decreased activity  moderates excitment calms recipient |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
produces drowsiness facilitates the onset and maintenance of a state of sleep that resembles natural sleep in its electorencephalographic characteristics recipient can be aroused easily from    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
can be benzodiazepines or non benzodiazepines   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 
All have similar pharm profiles, but differ in selectivity therefore variability among clinical usefulness of BZD agents |  | 
        |  | 
        
        | Term 
 
        | CNS effects of Benzodiazepines |  | Definition 
 
        |   
sedation→hypnosis→stupor (as dose ↑)do not cause true gen. anesthesia b/c awareness usually persists, and relaxation to allow surgery cannot be achievedUsed as pre-anesthetic to cause amnesia for events subsequent to admin.(Dose dependent)Hypnotic: effect different stages of sleep   |  | 
        |  | 
        
        | Term 
 
        | Respiratory effects of Benzodiazepines |  | Definition 
 
        | cause respiratory depression especially in:   
high dosesCOPDif given with other resp. depressants (i.e opioids)   |  | 
        |  | 
        
        | Term 
 
        | Cardiovascular effects of Benzodiazepines |  | Definition 
 
        | 
 
minor in normal patientsIn diazepam inj, cardio and resp depressant effects may be caused in part by the propylene glycol vehicle present |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 
hepatic (CYP3A4) metabolized many of their metabolites are pharm active with long t1/2. (cumulative effects with multiple doses)
 |  | 
        |  | 
        
        | Term 
 
        | Non-Benzodiazepine hypnotics |  | Definition 
 
        | 
 
structurally unrelated to BZD, but share similar mech of actionmore selecitve for α1 subunit of GABA receptor (thus more specific for sedation with fewer other BZD adverse effects: anxiolytic, muscle relaxant, amnesic effects) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Partial: simple partial Complex partial Generalized:  Absence (petit mal) Myoclonic Tonic-clonic (grand mal) Febrile Status epilepticus |  | 
        |  | 
        
        | Term 
 
        | Anti epileptic drug (AED) classes |  | Definition 
 
        | I) mostly enhance Na+ channel-mediated inhibition II) mostly inhibit Ca2+ channels III) enhance GABA mediated inhibition IV) Mixed actions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 
Broad spectrum (reasonable initial choice)Narrow spectrum |  | 
        |  |